Evidence map›Paper›PMID 21159556›Full record

ReviewTrends in immunology2011

To B or not to B: B cells and the Th2-type immune response to helminths.

Nicola Harris, William C Gause

Abstract readReview
In one paragraph

Review in Trends in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Egg-driven immunosuppression and granuloma zonation in Peyer's patches of mice withFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Type 2 immunity in the brain and brain borders.Cellular & molecular immunology · 2023
    Review
  14. Review
  15. M1/M2 macrophages and their overlaps - myth or reality?Clinical science (London, England : 1979) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicola HarrisSwiss Vaccine Research Institute and Global Health Institute, Ecole Polytechnique Fédérale, Lausanne, Switzerland.
William C Gause

Funding

CYTOKINE GENE EXPRESSION DURING IN VIVO IMMUNE RESPONSER01AI031678 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI GAUSE, WILLIAM CLARK · 1994 to 2013
$4.2M
Heminth Modulation of MtbR01AI069395 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SALGAME, PADMINI · 2007 to 2011
$2.8M
Gr-1+ cells and the response to nematode parasitesR01AI066188 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI GAUSE, WILLIAM CLARK · 2006 to 2010
$1.9M
NIAID NIH HHS R01 AI031678NIAID NIH HHS R01AI031678NIAID NIH HHS R01 AI066188NIAID NIH HHS R01 AI069395NIAID NIH HHS R01AI069395NIAID NIH HHS R01AI66188
6 · The paper itself

Abstract

Similar T helper (Th)2-type immune responses are generated against different helminth parasites, but the mechanisms that initiate Th2 immunity, and the specific immune components that mediate protection against these parasites, can vary greatly. B cells are increasingly recognized as important during the Th2-type immune response to helminths, and B cell activation might be a target for effective vaccine development. Antibody production is a function of B cells during helminth infection and understanding how polyclonal and antigen-specific antibodies contribute should provide important insights into how protective immunity develops. In addition, B cells might also contribute to the host response against helminths through antibody-independent functions including, antigen presentation, as well as regulatory and effector activity. In this review, we examine the role of B cells during Th2-type immune response to these multicellular parasites.

Indexed as

AnimalsAntibodies, HelminthB-LymphocytesHelminthiasisHelminthsHumansTh2 CellsVaccinationAntibodies, Helminth

Identifiers

PMID21159556
PMCPMC3076625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.